Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Clinicopathological significance of GADD45 gene alterations in human familial breast carcinoma.

Sensi E, Tancredi M, Aretini P, Cipollini G, Collecchi P, Naccarato AG, Viacava P, Bevilacqua G, Caligo MA.

Breast Cancer Res Treat. 2004 Sep;87(2):197-201.

PMID:
15377844
[PubMed - indexed for MEDLINE]
2.

Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.

Bartkova J, Tommiska J, Oplustilova L, Aaltonen K, Tamminen A, Heikkinen T, Mistrik M, Aittomäki K, Blomqvist C, Heikkilä P, Lukas J, Nevanlinna H, Bartek J.

Mol Oncol. 2008 Dec;2(4):296-316. doi: 10.1016/j.molonc.2008.09.007. Epub 2008 Oct 7.

PMID:
19383352
[PubMed - indexed for MEDLINE]
Free Article
3.

A polymorphism but no mutations in the GADD45 gene in breast cancers.

Blaszyk H, Hartmann A, Sommer SS, Kovach JS.

Hum Genet. 1996 Apr;97(4):543-7.

PMID:
8834260
[PubMed - indexed for MEDLINE]
4.

Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas.

Rhiem K, Todt U, Wappenschmidt B, Klein A, Wardelmann E, Schmutzler RK.

Anticancer Res. 2010 Sep;30(9):3445-9.

PMID:
20944121
[PubMed - indexed for MEDLINE]
5.

Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer.

Yamasawa K, Nio Y, Dong M, Yamaguchi K, Itakura M.

Clin Cancer Res. 2002 Aug;8(8):2563-9.

PMID:
12171884
[PubMed - indexed for MEDLINE]
Free Article
6.

Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.

Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SS, Das BC.

Breast Cancer Res Treat. 2004 Nov;88(2):177-86.

PMID:
15564800
[PubMed - indexed for MEDLINE]
7.

Induction of the p53-target gene GADD45 in HPV-positive cancer cells.

Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F.

Oncogene. 1999 Apr 8;18(14):2381-6.

PMID:
10327059
[PubMed - indexed for MEDLINE]
Free Article
8.

Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.

Gras E, Cortes J, Diez O, Alonso C, Matias-Guiu X, Baiget M, Prat J.

Cancer. 2001 Aug 15;92(4):787-95.

PMID:
11550149
[PubMed - indexed for MEDLINE]
9.

Loss of heterozygosity in bilateral breast cancer.

Kollias J, Man S, Marafie M, Carpenter K, Pinder S, Ellis IO, Blamey RW, Cross G, Brook JD.

Breast Cancer Res Treat. 2000 Dec;64(3):241-51.

PMID:
11200774
[PubMed - indexed for MEDLINE]
10.

Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.

Weber F, Shen L, Fukino K, Patocs A, Mutter GL, Caldes T, Eng C.

Am J Hum Genet. 2006 Jun;78(6):961-72. Epub 2006 Apr 12.

PMID:
16685647
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.

Kannan K, Krishnamurthy J, Feng J, Nakajima T, Tsuchida N, Shanmugam G.

Int J Oncol. 2000 Nov;17(5):1031-5.

PMID:
11029509
[PubMed - indexed for MEDLINE]
12.

The GADD45, ZBRK1 and BRCA1 pathway: quantitative analysis of mRNA expression in colon carcinomas.

Garcia V, García JM, Peña C, Silva J, Domínguez G, Rodríguez R, Maximiano C, Espinosa R, España P, Bonilla F.

J Pathol. 2005 May;206(1):92-9.

PMID:
15772983
[PubMed - indexed for MEDLINE]
13.

Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.

Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P.

Hum Mutat. 2005 Mar;25(3):319.

PMID:
15712267
[PubMed - indexed for MEDLINE]
14.

Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population.

Cao AY, Jin W, Shi PC, Di GH, Shen ZZ, Shao ZM.

Breast Cancer Res Treat. 2010 Jan;119(2):295-303. doi: 10.1007/s10549-009-0349-6. Epub 2009 Feb 24.

PMID:
19238535
[PubMed - indexed for MEDLINE]
15.

BRCA1 activation of the GADD45 promoter.

Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace AJ Jr, Zhan Q.

Oncogene. 2000 Aug 17;19(35):4050-7.

PMID:
10962562
[PubMed - indexed for MEDLINE]
16.

Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.

Otis CN, Krebs PA, Albuquerque A, Quezado MM, San Juan X, Sobel ME, Merino MJ.

Int J Surg Pathol. 2002 Oct;10(4):237-45.

PMID:
12490973
[PubMed - indexed for MEDLINE]
17.

Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437.

Rishi AK, Sun RJ, Gao Y, Hsu CK, Gerald TM, Sheikh MS, Dawson MI, Reichert U, Shroot B, Fornace AJ Jr, Brewer G, Fontana JA.

Nucleic Acids Res. 1999 Aug 1;27(15):3111-9.

PMID:
10454607
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.

Zhan Q, Fan S, Smith ML, Bae I, Yu K, Alamo I Jr, O'Connor PM, Fornace AJ Jr.

DNA Cell Biol. 1996 Oct;15(10):805-15.

PMID:
8892753
[PubMed - indexed for MEDLINE]
19.

Gadd45 mutations are uncommon in human tumour cell lines.

Campomenosi P, Hall PA.

Cell Prolif. 2000 Oct;33(5):301-6.

PMID:
11063132
[PubMed - indexed for MEDLINE]
20.

Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.

Ghimenti C, Sensi E, Presciuttini S, Brunetti IM, Conte P, Bevilacqua G, Caligo MA.

Genes Chromosomes Cancer. 2002 Mar;33(3):235-42.

PMID:
11807980
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk